HCC CONNECT is an international group of experts in the field of hepatocellular carcinoma and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
HCC CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.
Explore treatment options, adverse event management and next steps in this interactive patient case
Explore treatment selection and optimal sequencing after progression on immunotherapy in an interactive patient case video
Data from an Asia-Pacific patient and HCP survey
2nd line treatment selection and the right time to switch
Episode 4: Panel Discussion and Summary